International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Medication Therapy Management Implementation, Part 3: Barriers and Recommendations to Overcome Barriers

Author(s): Fyke Jeremy P, Yale Robert N, Corbett Corinne, Litera Natalie

Issue: Nov/Dec 2008 - Arthritis and Immunological Diseases
View All Articles in Issue

Page(s): 508-513

Medication Therapy Management Implementation, Part 3: Barriers and Recommendations to Overcome Barriers Page 1

Medication Therapy Management Implementation, Part 3: Barriers and Recommendations to Overcome Barriers Page 2

Medication Therapy Management Implementation, Part 3: Barriers and Recommendations to Overcome Barriers Page 3

Medication Therapy Management Implementation, Part 3: Barriers and Recommendations to Overcome Barriers Page 4

Medication Therapy Management Implementation, Part 3: Barriers and Recommendations to Overcome Barriers Page 5

Medication Therapy Management Implementation, Part 3: Barriers and Recommendations to Overcome Barriers Page 6

Download in electronic PDF format for $75

Abstract: As a required service of the Medicare Modernization Act of 2003, medication therapy management services must be offered by all Part D prescription drug-plan sponsors in order to improve overall knowledge of medication usage for targeted patients. Those targeted patients include patients who have multiple chronic diseases, have been prescribed several covered Part D medications, and are paying at least $4,000 for their medication each year. This article discusses some of the barriers and recommendations to overcome such barriers encountered by Indiana pharmacists.

Related Keywords: Jeremy P. Fyke, MA, Robert N. Yale, MA, Corinne Corbett, BA, Natalie Litera, BA, Medicare Modernization Act of 2003, Medicare Part D, medication therapy management, chronic disease, barriers to implementation

Related Categories: LEGAL, PATIENT EDUCATION, PHARMACY EDUCATION, PROFESSIONAL ISSUES

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Veterinary Transdermal Medications: A to Z Davidson Gigi S	Mar/Apr 2003 Pg. 106-113
Medication Therapy Management Implementation, Part 3: Barriers and Recommendations to Overcome Barriers Fyke Jeremy P, Yale Robert N, Corbett Corinne, Litera Natalie	Nov/Dec 2008 Pg. 508-513
Medication Therapy Management Implementation, Part 2: Study Methodologies, Barriers, and Recommendations to Overcome Barriers Fyke Jeremy P, Yale Robert N, Corbett Corinne, Litera Natalie	Sep/Oct 2008 Pg. 414-418
Recommendations for Overcoming Barriers to Medication Therapy Management Implementation, Part 1: Review of Literature Fyke Jeremy P, Yale Robert N, Corbett Corinne, Litera Natalie	Jul/Aug 2008 Pg. 329-333
Technology Spotlight: Barrier Isolators Moussa Magdy, Rahe Hank, Lo Katharine	Jan/Feb 2003 Pg. 42-43
The Science Behind Hormone Replacement Therapy, Part 1 Wepfer Scott T	Nov/Dec 2001 Pg. 462-464
Evaluating Transdermal Medication Forms for Veterinary Patients, Part 1 Davidson Gigi S	Mar/Apr 2001 Pg. 95-96
Bioidentical Hormone Replacement Therapy, Part 3, A Review of Wepfer Scott T	Mar/Apr 2002 Pg. 142-146
Evaluating Transdermals Medication Froms for Veterinary Patients, Part 2 Davidson Gigi S	May/Jun 2001 Pg. 214-215
Home Infusion: Overcoming the Barriers to Entry Franklin David M	Nov/Dec 2010 Pg. 450-455
Stability of Vancomycin HCl in MEDICATION CASSETTE Reservoirs Allen Loyd V Jr, Stiles M Lou	Mar/Apr 1997 Pg. 123-124
Sterile Compounding with Barrier-Isolation Technology Rahe Hank	Jul/Aug 2001 Pg. 254-258
Controlled Environment Testing Association Applications Guide for the Use of Barrier Isolators in Compounding Sterile Preparations in Healthcare Facilities, Part 1 Wagner James T	Mar/Apr 2006 Pg. 128-133
Controlled Environment Testing Association Applications Guide for the Use of Barrier Isolators in Compounding Sterile Preparations in Healthcare Facilities, Part 2 Wagner James T	May/Jun 2006 Pg. 208-211
Subcutaneous Testosterone Anastrozole Therapy in Men: Rationale, Dosing, and Levels on Therapy Glaser Rebecca L, York Anne E	Jul/Aug 2019 Pg. 325-339
PreScription: Drug Quality and Security Act Implementation Subcommittee Hearing Allen Loyd V Jr	Mar/Apr 2018 Pg. 92
Combating Cardiovascular Disease with Compounded Medications -- Part 2: Clinical and Compounding Issues for Antihypertensive Drugs Harrington Catherine A, Cauffield Jacintha	May/Jun 2005 Pg. 201-205
Evaluating Transdermal Medication Forms for Veterinary Patients, Part 3: Methimazole Davidson Gigi S	Jul/Aug 2001 Pg. 282-283
Bioidentical Hormone Replacement Therapy, Part 2, A Review of Wepfer Scott T	Jan/Feb 2002 Pg. 50-54
Hormone Replacement Therapy, Part 2: Estrogen Defined Lorentzen Jean	Nov/Dec 2001 Pg. 460-461
Return to Top